When HERG-caused LQT2 encounters antisense oligonucleotide: is exon 6 skipping therapy plausible?

The unique in-frame exon 6 of the HERG gene as a potential target for antisense oligonucleotide-mediated exon skipping therapy.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2025-03-21
DOI
https://doi.org/10.3389/fphar.2025.1535259
Citations
1
Primary Topic
Cardiac electrophysiology and arrhythmias
Type
article
Field-Weighted Citation Impact
1.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

When HERG-caused LQT2 encounters antisense oligonucleotide: is exon 6 skipping therapy plausible?

Yongfei Song, Zequn Zheng
1 citations
Frontiers in Pharmacology
Cardiac electrophysiology and arrhythmias
1.39
article

When HERG-caused LQT2 encounters antisense oligonucleotide: is exon 6 skipping therapy plausible?

Yongfei Song, Zequn Zheng
article en
1 citations

Abstract

The unique in-frame exon 6 of the HERG gene as a potential target for antisense oligonucleotide-mediated exon skipping therapy.

Frontiers in PharmacologyVol. 16
Ningbo University (CN), Shantou University (CN), Ningbo Medical Center Lihuili Hospital (CN), First Affiliated Hospital of Shantou University Medical College (CN)
Quality Education
Openalex Percentile: Top 21%
Cardiac electrophysiology and arrhythmias
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.